In our cohort, one CMO was found to bear a rare GNAQ p.R183G mutation which was only reported in several PWS cases [41–43], and 2 CMO patients had PIK3CA mutations [44]. This evidence concerns the gene PIK3CA and Prader-Willi syndrome.